课题基金 / 基金详情

Nutrient Sensing and Transcriptional Regulation

Nutrient Sensing and Transcriptional Regulation
营养感应和转录调节
批准号:
10174861
负责人:
Donald E Ayer
金额:
$39.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2023-06-30

项目摘要

项目成果

Donald E Ayer的其他基金

相似基金

相关文献

中文摘要
翻译
乳腺癌是一种异质性疾病,由几种临床和分子上不同的疾病组成
英文摘要
SUMMARY Breast cancer is a heterogeneous disease consisting of several clinically and molecularly distinct subtypes. Compared to other subtypes, Triple Negative Breast Cancer (TNBC), which represents 15-20% of all breast cancer, occurs at a younger age and recurs more frequently with a reduced survival rate. Currently, no targeted therapies are available for TNBC. Our short-term goal is to dissect the molecular pathways that support TNBC growth and survival. Our long-term goal is to leverage these discoveries to identify novel targets suitable for therapeutic development. We focus on how normal cells and cancer cells integrate intra- and extracellular growth and nutrient signals to sustain growth and tumorigenesis. We are most interested in how two members of the extended Myc network of transcription factors integrate growth and nutrient signals. c-Myc and MondoA function in opposition to control the aggressive growth and survival of TNBC. In this application we focus on the control of gene expression by MondoA and how metabolism shapes the MondoA-dependent transcriptome in vitro and in vivo. MondoA is the principal regulator of glucose-dependent transcription with Thioredoxin Interacting Protein (TXNIP) being its best-characterized direct and glucose-induced transcriptional target. TXNIP has pleiotropic function. Best characterized among these many functions is one in fuel choice. TXNIP is a potent suppressor of glucose uptake and aerobic glycolysis, but it can also drive the catabolism of other fuels such as branched chain amino acids and ketones in mitochondria. Thus, high TXNIP levels drive fuel oxidation in mitochondria, while restricting utilization of glucose. Conversely, low TXNIP levels tip fuel use towards glucose and away from mitochondria. We have shown that several predominant oncogenes block MondoA transcriptional activity, thereby decreasing TXNIP levels. This likely contributes to oncogene- dependent aerobic glycolysis, i.e. the Warburg Effect, which is a common feature of cancer cells. We propose to study how fuel choice controls MondoA transcriptional activity in vitro and in vivo and how signals from the tumor microenvironment dictate MondoA transcriptional activity. In Aim 1, we will determine how TXNIP, hypoxia and how the balance between glycolysis and oxidative phosphorylation controls MondoA transcriptional activity. In Aim 2, we will determine whether MondoA is required for the establishment or maintenance of tumorigenesis and whether MondoA is transcriptionally active in well perfused/oxygenated tumor regions. To examine the generality of our findings, we will determine MondoA’s role in gene expression and nutrient-sensing using other breast cancer cell lines and in conditionally reprogrammed breast cancer cells from PDX models. In Aim 3, we will use genomics approaches to discover the direct MondoA-dependent transcriptome in vivo and determine how these genes collaborate with MondoA to sustain TNBC tumorigenesis. We will also discover the cofactors required for MondoA transcriptional activity in vivo using biotin proximity labeling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Huntsman Cancer Institute (HCI) Cancer Genetics, Epigenetics, Models, and Signaling (Cancer GEMS) Training Program
  • 批准号:
    10627604
  • 项目类别:
  • 资助金额:
    $19.69万
  • 财政年份:
    2023
  • 负责人:
    Donald E Ayer
  • 依托单位:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
  • 批准号:
    10474257
  • 项目类别:
  • 资助金额:
    $54.0万
  • 财政年份:
    2019
  • 负责人:
    Donald E Ayer
  • 依托单位:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
  • 批准号:
    9792209
  • 项目类别:
  • 资助金额:
    $42.03万
  • 财政年份:
    2019
  • 负责人:
    Donald E Ayer
  • 依托单位:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
  • 批准号:
    10661674
  • 项目类别:
  • 资助金额:
    $53.93万
  • 财政年份:
    2019
  • 负责人:
    Donald E Ayer
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: